Institutional Career Development Core
Institutional Career Development Core
批准号:
9414515
负责人:
VICKI L ELLINGROD
金额:
$138.29万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2022-02-28
关键词:
AcademyClinicalClinical ResearchDental crownsDiverse WorkforceGenerationsGoalsGrantHealthInstitutesInternshipsLeadershipMentorsMentorshipMichiganPeer ReviewPrincipal InvestigatorPublicationsPublishingResearchTrainingTranslational Researchcareer developmentcohortexternshipimprovedprogramsresearch and developmentskillssupport network
中文摘要
密歇根大学临床与健康研究所(MICHR)认识到需要一个高技能,多样化的
我们的团队能够进行有影响力的临床和转化研究,以改善健康。以来
自MICHR成立以来,发展多元化的翻译人才队伍一直是一个一贯的优先事项。的
我们努力的“皇冠上的宝石”一直是KL 2计划,它吸引并开发了特殊的
学者自MICHR成立以来,KL 2学者(n=36)发表了超过1,000篇同行评审的
出版物(中位数=21),并作为主要研究者获得> 1.55亿美元的赠款支持(> 400万美元/
学者)。重要的是,97%的KL 2毕业生留在临床和转化研究,
2006-2011年的学员中有85%已成功晋升。我们现在建议改进这一方案
通过新的职业发展学院、职业发展跟踪
通过电子档案,为KL 2导师和学者提供正式的导师培训,扩大实习,
实习机会,以及更强大的支持网络,因为我们的KL 2学者过渡到独立。
人权专员办事处的目标是通过培训和指导新一代的
KL 2学者
英文摘要
The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly-skilled, diverse
workforce that can conduct impactful clinical and translational research that improves health. Since the
inception of MICHR, the development of a diverse translational workforce has been a consistent priority. The
“crown jewel” of our efforts has been the KL2 program, which has attracted and developed exceptional
scholars. Since the inception of MICHR, KL2 scholars (n=36) have published >1,000 peer-reviewed
publications (median=21) and received >$155M in grant support as principal investigators (>$4 million per
scholar). Importantly, 97% of all KL2 graduates have remained in clinical and translational research and
85% of the 2006-2011 cohorts have been successfully promoted. We now propose to improve this program
with enhanced leadership skills through a new Career Development Academy, career development tracking
with electronic portfolios, formal mentorship training for KL2 mentors and scholars, expanded internship and
externship opportunities, and a stronger network of support as our KL2 scholars transition to independence.
MICHR’s goal is the creation of greater positive impact through training and mentoring a new generation of
KL2 scholars.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CTSA Predoctoral T32 at the University of Michigan
-
批准号:10620888
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2023
-
负责人:VICKI L ELLINGROD
-
依托单位:
CTSA K12 Program at the University of Michigan
-
批准号:10621008
-
项目类别:
-
资助金额:$162.0万
-
财政年份:2023
-
负责人:VICKI L ELLINGROD
-
依托单位:
Development, Implementation and AssessMent of Novel Training in Domain-based Competencies (DIAMOND)
-
批准号:9319951
-
项目类别:
-
资助金额:$81.62万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Institutional Career Development Core
-
批准号:10116515
-
项目类别:
-
资助金额:$138.29万
-
财政年份:2017
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics - Gender Supplement
-
批准号:8797754
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8578175
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8019472
-
项目类别:
-
资助金额:$33.43万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:8213443
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8884655
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9098787
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7760595
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:9301028
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8705013
-
项目类别:
-
资助金额:$38.22万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Antipsychotic and Folate Pharmacogenetics
-
批准号:8931314
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
-
批准号:7617851
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2008
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:7040750
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2004
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6905615
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6529325
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6649155
-
项目类别:
-
资助金额:$15.38万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
Genetics of Antipsychotic Metabolism
-
批准号:6366012
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2001
-
负责人:VICKI L ELLINGROD
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: